News

Not-to-be-missed webinar takes place next week

18 Apr 24

A reminder that a not-to-be-missed webinar takes place next week!Candesic Senior Partner Dr Michelle Tempest will be kicking off the Royal Society of Medicine 'Insights into AI healthcare: Patient perspectives and clinical realities' event on Tuesday next week.Delve into AI's impact on ...

Candesic Senior Partner Dr Michelle Tempest as a podcast guest

7 Dec 23

Candesic Senior Partner Dr Michelle Tempest joined Abdul Rahyead as a guest on a new episode of The Scrubbed In Show Podcast. The conversation centered on the transition from a career in acute psychiatry to becoming a management consultant, on her passion for making a positive impact ...

Will AI ever replace human clinical teams?

5 Jun 23

At the Stifel AI conference organized by Stifel Financial Corp., the healthcare panel, moderated by David Vignon, CFA, had a lively debate around whether AI will ever replace human clinical teams. Dr Michelle Tempest from Candesic highlighted the urgent need for digital technology to help the ...

Candesic partner Dr Michelle Tempest harnessing the potential of Artificial Intelligence

2 Jun 23

Candesic Senior Partner and author of “Big Brain Revolution: Artificial Intelligence Spy or Saviour?" Dr Michelle Tempest shared her knowledge and expertise in a new article published by Harris Eyre, Rice University`s Baker Institue for Public Policy.With the significant potential of AI on ...

Digital health market set for shake-out

16 May 23

Amid continued double-digit growth in digital healthcare, the competitive landscape is expected to consolidate over coming years. Dr Michelle Tempest, Senior Partner at Candesic, spoke with LaingBuisson HealthcareMarkets UK about what it takes in the current climate for businesses to succeed in ...

How bright is the future for Digital Therapeutics across Europe?

11 May 23

Candesic Senior Partners Marc Kitten and Dr Michelle Tempest cover rapidly growing DTx Europe market in the newest ImpactX2050 report powered by IBIS Capital & Tyton Partners. Candesic investigates current state of Digital Therapeutics, its opportunities, implications and what`s next.

Metaverse for Healthcare

30 Mar 23

Tomorrow 31st March 3PM (UK time) join Candesic Senior Partner Dr Michelle Tempest on Twitter Space "Metaverse for Healthcare" in collaboration with Web3.Chairing the discussion will be the one and only Dr Christina Yan Zhang (CEO of The Metaverse Institute, Founding Member of World ...

The art of E-prescribing

25 Aug 22

E-prescribing has the potential to improve patient safety and reduce provider costs. It has been identified by the NHS as a key plank in its digital transformation programme. But implementation is not without its pitfalls and healthtech companies will need to do more than produce sophisticated ...

Why are Fintech Merger & Acquisitions on the rise in 2022?

21 Jul 22

Candesic's Partner, Marc Kitten, has been quoted in the FinTech Magazine. He commented "the merger and acquisitions boom is a natural progression of industry growth".

Digital clinical trials in a new era

6 Apr 22

Dr Michelle Tempest, Partner and George Holden from Candesic are excited to share their thoughts on ‘digital clinical trials’.The silver lining of Covid19 has been to show the power of working together to collect real world evidence - special thanks to all people (patients and NHS staff) ...